Dr. Yoon-Jae Y Cho, MD
0 Patient Reviews

Dr. Yoon-Jae Y Cho, MD

Neurologist - Special Qualifications in Child Neurology


  • Board Certified
  • Accepts Insurance Plans


Dr. Yoon-Jae Y Cho, MD is a Neurologist - Special Qualifications in Child Neurology practicing in Palo Alto, CA

He has not yet shared a personalized biography with Doctor.com.

Are you Dr. Yoon-Jae Y Cho, MD?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Provider Training

Internship - Children's Hospital of Pittsburgh, Pittsburgh PA (2003) Not Specified
Internship - Children's Hospital of Pittsburgh PA (2003)Not Specified
Fellowship - Children's Hospital Boston, Boston MA 2008
Fellowship - Children's Hospital Boston MA 2008

CertificationCert. BodyYear
Neurology with Special Qualification in Child NeurologyPsychiatry and Neurology2009

Experience & Accolades

Faculty Development Award, Shore Fellowship Program for Scholars in Me 2009-2011
Young Investigator Award, Pediatric Brain Tumor Foundation 2007
Laurel MD-PhD Scholar, Oregon Medical Research Foundation 1994-2002
Biology Committee, Pediatric Brain Tumor Consortium 2012
Philip R. Dodge Young Investigator Award, Child Neurology Society 2012
Beirne Faculty Scholar in Pediatirc Neuro-oncology, Stanford Universi 2011
Scholar, St. Baldrick's Foundation 2011

Publication Publisher Title Published
Other Publicationture medicineEpigenetic targeting of Hedgehog pathway transcriptiol output through BET bromodomain inhibition.2014
Other PublicationCancer cellReduced H3K27me3 and D Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant2013
Other PublicationTUREMedulloblastoma exome sequencing uncovers subtype-specific somatic mutations2012
Other PublicationJOURL OF CLINICAL ONCOLOGYIntegrative Genomic Alysis of Medullobl2011
Other PublicationACTA NEUROPATHOLOGICAalpha 5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth2014
Other PublicationJOURL OF CLINICAL ONCOLOGYCytogenetic Prognostication Within Medulloblastoma Subgroups2014
Other PublicationCANCER CELLGenome Sequencing of SHH Medulloblastoma Predicts Genotype2014
Other PublicationJourl of neuro-oncologyDiffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct2014
Other PublicationClinical cancer researchBET Bromodomain Inhibition of MYC-Amplified Medulloblastoma.2014
Other PublicationACTA NEUROPATHOLOGICAMedulloblastoma Down Under 20132014
Other PublicationActa neuropathologicaTERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.2013
Other Publicationlancet oncologyRecurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular alysis.2013
Other PublicationJourl of clinical oncologySubgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma.2013
Other Publicationture geneticsRecurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.2013
Other PublicationtureBAF complexes facilitate decatetion of D by topoisomerase IIa.2013
Other PublicationProceedings of the tiol Academy of Sciences of the United States of AmGenomic alysis of diffuse pediatric low2013
Other PublicationMOLECULAR CANCER RESEARCHInhibition of TWIST1 Leads to Activation of Oncogene-Induced Senescence in Oncogene2013
Other PublicationMOLECULAR CANCERGrowth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 sigling2013
Other PublicationOncogeneActivation of ?-catenin/TCF targets following loss of the tumor suppressor SNF5.
Other PublicationCOLD SPRING HARBOR PERSPECTIVES IN MEDICINEThe VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward2012
Other PublicationTURE REVIEWS CANCERMedulloblastomics: the end of the beginning2012
Other PublicationTURESubgroup-specific structural variation across 1,000 medulloblastoma genomes2012
Other PublicationTUREDissecting the genomic complexity underlying medulloblastoma2012
Other PublicationCELL CYCLEEpigenetic ictivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors2012
Other PublicationPLOS GENETICSTwist1 Suppresses Senescence Programs and Thereby Accelerates and Maintains Mutant Kras2012
Other PublicationACTA NEUROPATHOLOGICARapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples2012
Other PublicationACTA NEUROPATHOLOGICAMolecular subgroups of medulloblastoma2012
Other PublicationACTA NEUROPATHOLOGICAMicroR-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma2012
Other PublicationACTA NEUROPATHOLOGICAPleiotropic effects of miR-183 similar to 96 similar to 182 converge to regulate cell survival2012
Other PublicationACTA NEUROPATHOLOGICAMolecular subgroups of medulloblastoma: the current consensus2012
Other PublicationACTA NEUROPATHOLOGICABiological and clinical heterogeneity of MYCN-amplified medulloblastoma2012
Other PublicationTUREClol selection drives genetic divergence of metastatic medulloblastoma2012
Other PublicationCANCER CELLAn Animal Model of MYC-Driven Medulloblastoma2012
Other PublicationClinical cancer researchExpression of FoxM1 is required for the proliferation of medulloblastoma cells2011
Other PublicationCANCER CELLDelineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma2011
Other PublicationJOURL OF CLINICAL ONCOLOGYPredicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical2011
Other PublicationFUTURE ONCOLOGYMolecular fingerprints of medulloblastoma and their application to clinical practice2011
Other PublicationNEURO-ONCOLOGYmiR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma2011
Other PublicationTURE COMMUNICATIONSTumour microvesicles contain retrotransposon elements and amplified oncogene sequences2011
Other PublicationTURE MEDICINELoss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway2010
Other PublicationNEURO-ONCOLOGYNeuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma2010
Other PublicationCANCER CELLEpigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation2010
Other PublicationTUREThe landscape of somatic copy-number alteration across human cancers2010
Other PublicationMOLECULAR AND CELLULAR BIOLOGYLoss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability2008

Practice & Hospital Affiliations

Dr. Yoon-Jae Y Cho, MD has not yet indicated the hospitals that he is affiliated with.


Provider Profile 0Provider Profile 1


Languages Spoken
Medical Specialties
  • Neurologist - Sub-Specialty: Special Qualifications in Child Neurology

Years In Practice: 12 (started in 2009)

Accepts New Patients: Yes

Accepted Insurance

Full Insurance List

Payment Options

Payment Details
We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.